Phage Therapy with a Focus on the Human Microbiota

Bacteriophages are viruses that infect bacteria. After their discovery in the early 1900s, bacteriophages were a primary cure against infectious disease for almost 25 years, before being completely overshadowed by antibiotics. With the rise of antibiotic resistance, bacteriophages are being explored...

Full description

Bibliographic Details
Main Authors: Sharita Divya Ganeshan, Zeinab Hosseinidoust
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/8/3/131
_version_ 1818337445128699904
author Sharita Divya Ganeshan
Zeinab Hosseinidoust
author_facet Sharita Divya Ganeshan
Zeinab Hosseinidoust
author_sort Sharita Divya Ganeshan
collection DOAJ
description Bacteriophages are viruses that infect bacteria. After their discovery in the early 1900s, bacteriophages were a primary cure against infectious disease for almost 25 years, before being completely overshadowed by antibiotics. With the rise of antibiotic resistance, bacteriophages are being explored again for their antibacterial activity. One of the critical apprehensions regarding bacteriophage therapy, however, is the possibility of genome evolution, development of phage resistance, and subsequent perturbations to our microbiota. Through this review, we set out to explore the principles supporting the use of bacteriophages as a therapeutic agent, discuss the human gut microbiome in relation to the utilization of phage therapy, and the co-evolutionary arms race between host bacteria and phage in the context of the human microbiota.
first_indexed 2024-12-13T14:55:19Z
format Article
id doaj.art-c2bd7177d7874286aad7cfb7838f726f
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-12-13T14:55:19Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-c2bd7177d7874286aad7cfb7838f726f2022-12-21T23:41:15ZengMDPI AGAntibiotics2079-63822019-08-018313110.3390/antibiotics8030131antibiotics8030131Phage Therapy with a Focus on the Human MicrobiotaSharita Divya Ganeshan0Zeinab Hosseinidoust1School of Biomedical Engineering, McMaster University, Hamilton, ON L8S 4K1, CanadaSchool of Biomedical Engineering, McMaster University, Hamilton, ON L8S 4K1, CanadaBacteriophages are viruses that infect bacteria. After their discovery in the early 1900s, bacteriophages were a primary cure against infectious disease for almost 25 years, before being completely overshadowed by antibiotics. With the rise of antibiotic resistance, bacteriophages are being explored again for their antibacterial activity. One of the critical apprehensions regarding bacteriophage therapy, however, is the possibility of genome evolution, development of phage resistance, and subsequent perturbations to our microbiota. Through this review, we set out to explore the principles supporting the use of bacteriophages as a therapeutic agent, discuss the human gut microbiome in relation to the utilization of phage therapy, and the co-evolutionary arms race between host bacteria and phage in the context of the human microbiota.https://www.mdpi.com/2079-6382/8/3/131microbiome therapyphage therapyevolutionantibiotic resistance
spellingShingle Sharita Divya Ganeshan
Zeinab Hosseinidoust
Phage Therapy with a Focus on the Human Microbiota
Antibiotics
microbiome therapy
phage therapy
evolution
antibiotic resistance
title Phage Therapy with a Focus on the Human Microbiota
title_full Phage Therapy with a Focus on the Human Microbiota
title_fullStr Phage Therapy with a Focus on the Human Microbiota
title_full_unstemmed Phage Therapy with a Focus on the Human Microbiota
title_short Phage Therapy with a Focus on the Human Microbiota
title_sort phage therapy with a focus on the human microbiota
topic microbiome therapy
phage therapy
evolution
antibiotic resistance
url https://www.mdpi.com/2079-6382/8/3/131
work_keys_str_mv AT sharitadivyaganeshan phagetherapywithafocusonthehumanmicrobiota
AT zeinabhosseinidoust phagetherapywithafocusonthehumanmicrobiota